The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

LRMR FINANCIAL STATEMENTS

Larimar Therapeutics Inc — balance sheet, income statement and cash flow trends

LRMRLarimar Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-150 M-100 M-50 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-87 K $ · -Infinity%Operating Income-179 M $ · -Infinity%Pre-tax Income-172.6 M $ · -Infinity%Net Income to Owners-172.6 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-87 K $—
Operating Income-179 M $—
EBITDA-172.3 M $—
Net Income to Owners-172.6 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0100 M200 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets165.3 M
  • Equity127.4 M $77%
  • Current Liabilities34.2 M $21%
  • Long-term Liabilities3.8 M $2%

Key Figures

YoY change
Total Assets165.3 M $+10.2%
Total Liabilities37.9 M $+25.8%
Total Equity127.4 M $+6.3%
Cash & ST Investments156.3 M $+12.8%
Total Debt5 M $+7.4%
Net Debt-87.7 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-150 M-100 M-50 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M0-155.9 M $Operating55.1 M $Investing172.8 M $Financing72 M $Net Change

Key Figures

YoY change
Operating Cash Flow-155.9 M $—
Capital Expenditures153 K $-50.5%
Free Cash Flow-156.1 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on LRMR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.